Assessment of in vivo bone microarchitecture changes in an anti-TNFα treated psoriatic arthritic patient.
<h4>Objective</h4>Psoriatic arthritis (PsA) is an inflammatory rheumatic disease, mediated in part by TNFα and associated with bone loss. Anti-TNFα treatment should inhibit this phenomenon and reduce the systemic bone loss. Ultra-high field MRI (UHF MRI) may be used to quantify bone micr...
Guardado en:
Autores principales: | Enrico Soldati, Lucas Escoffier, Sophie Gabriel, Augustin C Ogier, Christophe Chagnaud, Jean P Mattei, Serge Cammilleri, David Bendahan, Sandrine Guis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18a89909cce04386831e5f130afaf1c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021) -
In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
por: Shi Q, et al.
Publicado: (2018) -
TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
por: Sarin Somers, et al.
Publicado: (2017) -
AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Irmina Olejniczak-Staruch, et al.
Publicado: (2021) -
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
por: Thorlund K, et al.
Publicado: (2012)